PRELIMINARY TRIAL OF 9-HYDROXY-2-METHYL ELLIPTICINIUM (NSC 264-137) IN ADVANCED HUMAN CANCERS

被引：118

作者：

JURET, P

TANGUY, A

GIRARD, A

LETALAER, JY

ABBATUCCI, JS

DATXUONG, N

LEPECQ, JB

PAOLETTI, C

机构：

[1] CNRS, INST CHIM SUBST NAT, F-91190 GIF SUR YVETTE, FRANCE

[2] INST GUSTAVE ROUSSY, CHIMOTHERAPIE EXPT LAB, F-94800 VILLEJUIF, FRANCE

来源：

EUROPEAN JOURNAL OF CANCER | 1978年 / 14卷 / 02期

关键词：

D O I：

10.1016/0014-2964(78)90180-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：205 / 206

页数：2

相关论文

共 7 条

[1] METHOXY-9-ELLIPTICINE LACTATE IN REFRACTORY ACUTE MYELOID LEUKEMIA
ANSARI, BM
THOMPSON, EN
[J]. POSTGRADUATE MEDICAL JOURNAL, 1975, 51 (592) : 103 - 105
[2] SYNTHESIS OF TUMOUR-INHIBITORY ALKALOIDS ELLIPTICINE 9-METHOXYELLIPTICINE AND RELATED PYRIDO[4,3-B]CARBAZOLES
DALTON, LK
DEMERAC, S
ELMES, BC
LODER, JW
SWAN, JM
TEITEI, T
[J]. AUSTRALIAN JOURNAL OF CHEMISTRY, 1967, 20 (12) : 2715 - &
[3] NEW DNA INTERCALATING DRUG - METHOXY-9-ELLIPTICINE
FESTY, B
POISSON, J
PAOLETTI, C
[J]. FEBS LETTERS, 1971, 17 (02): : 321 - +
[4] LEPECQ JB, 1975, CR ACAD SCI D NAT, V281, P1365
[5] NEW ANTITUMORAL AGENT - 9-HYDROXYELLIPTICINE - POSSIBILITY OF A RATIONAL DESIGN OF ANTI-CANCEROUS DRUGS IN SERIES OF DNA INTERCALATING DRUGS
LEPECQ, JB
NGUYENDANGHUNG
GOSSE, C
PAOLETTI, C
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (12) : 5078 - 5082
[6] LEPECQ JB, 1976, CANCER RES, V36, P3067
[7] MATHE G, 1970, EUR J CLIN BIOL RES, V15, P541